$RNXT 4 SEC Filings

Filed On	Filing
02 Oct 2026	Form 4: Macfarlane K. Angela, Director Granted 55,924 Stock Options (right to buy)
02 Oct 2026	Form 4: Spiegel Robert J., Director Granted 55,924 Stock Options (right to buy)
02 Oct 2026	Form 4: Ryan Una S, Director Granted 55,924 Stock Options (right to buy)
02 Oct 2026	Form 4: Marton Laurence, Director Granted 55,924 Stock Options (right to buy)
15 Sep 2026	Form 4: Voll Mark, Chief Financial Officer Received 80,000 shares as a grant or award
24 Jun 2026	Form 4: Ryan Una S, Director Acquired 54,121 shares (Other Transaction) ($225K) · Acquired 43,044 shares (Other Transaction) ($51.3K)
21 May 2026	Form 4: Voll Mark, Chief Financial Officer Bought 25,000 shares ($19.7K)
07 Apr 2026	Form 4: Bagai Shaun, Director Granted 946,107 Stock Option
07 Apr 2026	Form 4: Voll Mark, Chief Financial Officer Received 80,000 shares as a grant or award
07 Apr 2026	Form 4: Gentry Leesa, Chief Clinical Officer Granted 128,550 Stock Option
07 Apr 2026	Form 4: Agah Ramtin, Director Granted 621,727 Stock Option
27 Mar 2026	Form 4: Voll Mark, Chief Financial Officer Received 12,380 shares as a grant or award
24 Mar 2026	Form 4: Marton Laurence, Director Bought 9,720 shares · Acquired 4,860 Warrants (Open Market Purchase)
24 Mar 2026	Form 4: Bagai Shaun, Director Bought 24,300 shares · Acquired 12,150 Warrants (Open Market Purchase)
24 Mar 2026	Form 4: Voll Mark, Chief Financial Officer Bought 97,200 shares · Acquired 48,600 Warrants (Open Market Purchase)
22 Jan 2026	Form 4: Agah Ramtin, Director Bought 10,000 shares ($9.98K)
05 Jan 2026	Form 4: Agah Ramtin, Director Bought 9,795 shares ($8.42K)
02 Jan 2026	Form 4: Agah Ramtin, Director Bought 205 shares ($169)
22 Dec 2025	Form 4: Bagai Shaun, Director Bought 5,000 shares ($4.51K)
19 Dec 2025	Form 4: Bagai Shaun, Director Bought 5,000 shares ($4.26K)

Comments